{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:07:47Z","timestamp":1790665667192,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4-5","license":[{"start":{"date-parts":[[1997,4,1]],"date-time":"1997-04-01T00:00:00Z","timestamp":859852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1997,4]]},"DOI":"10.1007\/bf01277663","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T01:42:45Z","timestamp":1111628565000},"page":"451-459","source":"Crossref","is-referenced-by-count":31,"title":["Concentrations of indoleamine metabolic intermediates in the ventricular cerebrospinal fluid of advanced Parkinson's patients with severe postural instability and gait disorders"],"prefix":"10.1007","volume":"104","author":[{"given":"R. P.","family":"Iacono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Kuniyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Ahlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. D.","family":"Pearlstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/bmc.1130070605","volume":"7","author":"ME Alburges","year":"1993","unstructured":"Alburges ME, Narang N, Wamsley JK (1993) A sensitive and rapid HPLC-ECD method for the simultaneous analysis of norepinephrine, dopamine, serotonin and their primary metabolites in brain tissue. Biomed Chromatogr 7: 306?310","journal-title":"Biomed Chromatogr"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/0303-8467(92)90018-X","volume":"94","author":"BR Bloem","year":"1992","unstructured":"Bloem BR (1992) Postural instability in Parkinson's disease. Clin Neurol Neurosurg 94: S41?45","journal-title":"Clin Neurol Neurosurg"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1212\/WNL.37.9.1539","volume":"37","author":"AM Bonnet","year":"1987","unstructured":"Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y (1987) Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology 37: 1539?1542","journal-title":"Neurology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archneur.1972.00490180022006","volume":"27","author":"TN Chase","year":"1972","unstructured":"Chase TN, Ng LK (1972) Central monoamine metabolism in Parkinson's disease. Arch Neurol 27: 486?491","journal-title":"Arch Neurol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0306-4522(93)90240-G","volume":"54","author":"G Chinaglia","year":"1993","unstructured":"Chinaglia G, Landwehrmeyer B, Probst A, Palacios JM (1993) Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram. Neuroscience 54: 691?699","journal-title":"Neuroscience"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.410220207","volume":"22","author":"RJ D'Amato","year":"1987","unstructured":"D'Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL, Snyder SH (1987) Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol 22: 229?236","journal-title":"Ann Neurol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0022-510X(91)90169-8","volume":"103","author":"Y Furukawa","year":"1991","unstructured":"Furukawa Y, Kondo T, Nishi K, Yokochi F, Narabayashi H (1991) Total biopterin levels in the ventricular CSF of patients with Parkinson's disease: a comparison between akineto-rigid and tremor types. J Neurol Sci 103: 232?237","journal-title":"J Neurol Sci"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","volume":"510","author":"GM Halliday","year":"1990","unstructured":"Halliday GM, Blumbergs PC, Cotton RG, Blessing WW, Geffen LB (1990a) Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res 510: 104?107","journal-title":"Brain Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410270405","volume":"27","author":"GM Halliday","year":"1990","unstructured":"Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, Blessing WW, Geffen LB (1990b) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27: 373?385","journal-title":"Ann Neurol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01244998","volume":"93","author":"H Hashiguti","year":"1993","unstructured":"Hashiguti H, Nakahara D, Maruyama W, Naoi M, Ikeda T (1993) Simultaneous determination of in vivo hydroxylation of tyrosine and tryptophan in rat striatum by microdialysis-HPLC: relationship between dopamine and serotonin biosynthesis. J Neural Transm [Gen Sect] 93: 213?223","journal-title":"J Neural Transm [Gen Sect]"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1227\/00006123-199506000-00008","volume":"36","author":"RP Iacono","year":"1995","unstructured":"Iacono RP, Shima F, Lonser RR, Kuniyoshi S, Maeda G, Yamada S (1995) The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease [see comments]. Neurosurgery 36: 1118?11125 (discussion 1125?1127)","journal-title":"Neurosurgery"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02250926","volume":"8","author":"H Ichinose","year":"1994","unstructured":"Ichinose H, Ohye T, Fujita K, Pantucek F, Lange K, Riederer P, Nagatsu T (1994) Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia. J Neural Transm [Park Dis Dement Sect] 8: 149?158","journal-title":"J Neural Transm [Park Dis Dement Sect]"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2169\/internalmedicine1962.25.114","volume":"25","author":"T Indo","year":"1986","unstructured":"Indo T, Takahashi A (1986) An analysis of long-term L-dopa therapy in 122 cases of Parkinson's disease over 14 years ? when should L-dopa therapy be initiated? Jpn J Med 25: 114?121","journal-title":"Jpn J Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","volume":"40","author":"J Jankovic","year":"1990","unstructured":"Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, et al (1990) Variable expression of Parkinson's disease: a baseline analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529?1534","journal-title":"Neurology"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/0303-8467(92)90033-Y","volume":"94","author":"KA Jellinger","year":"1992","unstructured":"Jellinger KA, Paulus W (1992) Clinico-pathological correlations in Parkinson's disease. Clin Neurol Neurosurg 94: S86-S88","journal-title":"Clin Neurol Neurosurg"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mds.870010304","volume":"1","author":"HL Klawans","year":"1986","unstructured":"Klawans HL (1986) Individual manifestations of Parkinson's disease after ten or more years of levodopa. Mov Disord 1: 187?192","journal-title":"Mov Disord"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00002826-198904000-00003","volume":"12","author":"WC Koller","year":"1989","unstructured":"Koller WC, Glatt S, Vetere-Overfield B, Hassanein R (1989) Falls and Parkinson's disease. Clin Neuropharmacol 12: 98?105","journal-title":"Clin Neuropharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0404.1985.tb03176.x","volume":"71","author":"M Koskiniemi","year":"1985","unstructured":"Koskiniemi M, Laakso J, Kuurne T, Laipio M, Harkonen M (1985) Indole levels in human lumbar and ventricular cerebrospinal fluid and the effect of L-tryptophan administration. Acta Neurol Scand 71: 127?132","journal-title":"Acta Neurol Scand"},{"key":"CR19","first-page":"545","volume":"69","author":"E Melamed","year":"1996","unstructured":"Melamed E, Zoldan J, Friedberg G, Ziv I, Weizmann A (1996) Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy, Adv Neurol 69: 545?550","journal-title":"Adv Neurol"},{"key":"CR20","first-page":"263","volume":"43","author":"H Narabayashi","year":"1991","unstructured":"Narabayashi H, Yokochi F, Ogawa T, Igakura T (1991) Analysis of L-threo-3,4-dihydroxyphenylserine effect on motor and psychological symptoms in Parkinson's disease. No To Shinkei 43: 263?268","journal-title":"No To Shinkei"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","volume":"50","author":"W Paulus","year":"1991","unstructured":"Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 50: 743?755","journal-title":"J Neuropathol Exp Neurol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","volume":"275","author":"B Scatton","year":"1983","unstructured":"Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 275: 321?28","journal-title":"Brain Res"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(86)91446-0","volume":"380","author":"B Scatton","year":"1986","unstructured":"Scatton B, Dennis T, L'Heureux R, Monfort JC, Duyckaerts C, Javoy-Agid F (1986) Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients. Brain Res 380: 181?185","journal-title":"Brain Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/jnnp.38.7.666","volume":"38","author":"R Sjostrom","year":"1975","unstructured":"Sjostrom R, Ekstedt J, Anggard E (1975) Concentration gradients of monoamine metabolites in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry 38: 666?668","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CR25","first-page":"97","volume":"29","author":"TL Sourkes","year":"1975","unstructured":"Sourkes TL, Young SN, Garelis E, Lal S (1975) Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF). Acta Vitaminol Enzymol 29: 97?99","journal-title":"Acta Vitaminol Enzymol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00001756-199205000-00009","volume":"3","author":"MM Strittmatter","year":"1992","unstructured":"Strittmatter MM, Cramer H (1992) Parkinson's disease and dementia: clinical and neurochemical correlations. Neuroreport 3: 413?416","journal-title":"Neuroreport"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3940(93)90111-W","volume":"150","author":"H Tohgi","year":"1993","unstructured":"Tohgi H, Abe T, Takahashi S, Takahashi J, Hamato H (1993) Concentrations of serotonin and its related substances in the cereborspinal fluid of parkinsonian patients and their relations to the severity of symptoms. Neurosci Lett 150: 71?74","journal-title":"Neurosci Lett"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1472-8206.1991.tb00736.x","volume":"5","author":"JH Trouvin","year":"1991","unstructured":"Trouvin JH, Maubrey MC, Raynal H, Jacquot C (1991) Effect of L-dopa loading on 5-HTP decarboxylation in rat brain areas. Fundam Clin Pharmacol 5: 497?502","journal-title":"Fundam Clin Pharmacol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01277663.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01277663\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01277663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T14:10:44Z","timestamp":1556633444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01277663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":28,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["BF01277663"],"URL":"https:\/\/doi.org\/10.1007\/bf01277663","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}